Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Travere Therapeutics Inc (TVTX)

Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,302,567
  • Shares Outstanding, K 76,129
  • Annual Sales, $ 145,240 K
  • Annual Income, $ -111,400 K
  • 60-Month Beta 0.73
  • Price/Sales 9.26
  • Price/Cash Flow N/A
  • Price/Book 88.83
Trade TVTX with:

Options Overview Details

View History
  • Implied Volatility 85.95% ( -0.45%)
  • Historical Volatility 84.13%
  • IV Percentile 31%
  • IV Rank 42.80%
  • IV High 171.71% on 08/16/24
  • IV Low 21.77% on 07/15/24
  • Put/Call Vol Ratio 1.02
  • Today's Volume 454
  • Volume Avg (30-Day) 1,359
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 33,071
  • Open Int (30-Day) 23,221

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.71
  • Number of Estimates 8
  • High Estimate -0.57
  • Low Estimate -0.97
  • Prior Year -1.17
  • Growth Rate Est. (year over year) +39.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.89 +38.02%
on 09/12/24
18.60 -11.77%
on 10/10/24
+4.17 (+34.07%)
since 09/11/24
3-Month
7.93 +106.91%
on 08/05/24
18.60 -11.77%
on 10/10/24
+6.62 (+67.62%)
since 07/11/24
52-Week
5.12 +220.51%
on 04/25/24
18.60 -11.77%
on 10/10/24
+8.83 (+116.49%)
since 10/11/23

Most Recent Stories

More News
Travere: Q2 Earnings Snapshot

Travere: Q2 Earnings Snapshot

TVTX : 16.41 (-4.09%)
CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

/CNW/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that the European Commission has granted conditional marketing authorization...

TVTX : 16.41 (-4.09%)
CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy

/CNW/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that the European Medicines Agency's (EMA) CHMP has recommended approval of...

TVTX : 16.41 (-4.09%)
Why Shares of Travere Therapeutics Are Slumping Thursday

A mixed trial could hurt a kidney drug's chances of full approval.

MIRM : 40.11 (+4.24%)
TVTX : 16.41 (-4.09%)
3 Small-Cap Stocks That Could Be Big-Time Winners

These stocks come with significant risks. But they could generate huge returns over time.

BLUE : 0.5060 (+2.28%)
TVTX : 16.41 (-4.09%)
VKTX : 65.84 (+5.43%)
TVTX ALERT: The Law Offices of Vincent Wong Investigate Travere Therapeutics, Inc. for Potential Violations of Securities Laws

/PRNewswire/ -- Attention Travere Therapeutics, Inc. ("Travere") (NASDAQ: TVTX) shareholders: The Law Offices of Vincent Wong announce that an investigation...

TVTX : 16.41 (-4.09%)
TVTX FRAUD ALERT: Jakubowitz Law is Investigating Travere Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws

/PRNewswire/ -- Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Travere...

TVTX : 16.41 (-4.09%)
TVTX INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Travere Therapeutics, Inc.

/PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Travere Therapeutics, Inc. ("Travere") (NASDAQ: TVTX) concerning...

TVTX : 16.41 (-4.09%)
TVTX NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Travere Therapeutics, Inc.

/PRNewswire/ -- The Klein Law Firm announces that it is investigating allegations that Travere Therapeutics, Inc. ("Travere") (NASDAQ: TVTX) violated federal...

TVTX : 16.41 (-4.09%)
TVTX ALERT: The Law Offices of Vincent Wong Investigate Travere Therapeutics, Inc. for Potential Violations of Securities Laws

/PRNewswire/ -- Attention Travere Therapeutics, Inc. ("Travere") (NASDAQ: TVTX) shareholders: The Law Offices of Vincent Wong announce that an investigation...

TVTX : 16.41 (-4.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Travere Therapeutics Inc. is a biopharmaceutical company. It engages to identify, develop and deliver life-changing therapies. Travere Therapeutics Inc., formerly known as Retrophin Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 19.14
2nd Resistance Point 18.57
1st Resistance Point 17.49
Last Price 16.41
1st Support Level 15.84
2nd Support Level 15.27
3rd Support Level 14.19

See More

52-Week High 18.60
Last Price 16.41
Fibonacci 61.8% 13.45
Fibonacci 50% 11.86
Fibonacci 38.2% 10.27
52-Week Low 5.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar